BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Register
Register
Register

ProjectUpdated on 28 July 2026

Novel Platinum-Based Drug (HJ-550 )

CEO at Shanghai Haiju Biotechnology Co., Ltd.

China

About

A first-in-class targeted bivalent platinum drug exhibits overall superior efficacy over first-line standard-of-care treatments as monotherapy and in combination, holding potential to transform first-line tumor therapeutic strategies.

Project Location

  • China

Project Format

  • Private Project

Go Global Project

  • Yes

ESG (Environmental, Social, and Governance)

  • Yes

Project Stage

  • Investment / Financing Discussion

Main Project Sector

  • Technology

Technology

  • Bio-Tech

Total Project Value

  • 10,000,001 to 25,000,000 USD

Investment Capital Required

  • 500,001 to 1,000,000 USD

Interested Format of Cooperation

  • Convertible Loan
  • Direct Equity Investment
  • Joint Venture

Preferred Financing Model

  • Debt
  • Equity

Type(s) of Last Financing Round of the project (if Applicable)

  • Equity (private)

Main Service(s) Required

  • Financial Services
  • Professional Services

Financial Services

  • Institutional Investment
  • Investment Banking
  • Mergers & Acquisition
  • Private Equity & Venture Capital

Attached files

Similar opportunities